Additionally, coincident DAB2 and active-YAP1 upregulation was observed in GC tumor tissues and indicated a poor prognosis, indicating that elevated DAB2 and active-YAP1 expression levels served as predictive biomarkers for GC. The gene discussed is YAP1; the disease is gastric cancer.